logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jarin Chindaprasirt

Khon Kaen University
H指数:20
被引数:1,147

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective Phase II Study of Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma (NEOFOL)

NEOFOL研究：可切除胆管癌新辅助mFOLFOXIRI方案的二期前瞻性研究

International Journal of Cancer
IF4.7
2026-09-290
PRE
Attapol Titapun; Aumkhae Sookprasert; Kosin Wirasorn; Piyakarn Watcharenwong; Thanachai Sanlung; Vor Luvira; Tharatip Srisuk; Apiwat Jarearnrat; Vasin Thanasukarn; Julaluck Promsorn; Kulyada Somsap; Prin Twinprai; Piya Prajumwongs; Watcharin Loilome; Jarin Chindaprasirt
Incorporation of Microsatellite Instability and Tumor-Infiltrating Lymphocytes in Opisthorchis viverrini-Associated Cholangiocarcinoma: Predicting Patient Outcomes

微卫星不稳定性与肿瘤浸润淋巴细胞在猫后睾吸虫相关性胆管癌中的整合：预测患者预后

Journal of Molecular Pathology
IF1.1
2025-12-010
PRE
Khuntikeo, Natcha; Jareanrat, Apiwat; Thanasukarn, Vasin; Srisuk, Tharatip; Luvira, Vor; Loilome, Watcharin; Klanrit, Poramate; Techasen, Anchalee; Chindaprasirt, Jarin; Sa-Ngiamwibool, Prakasit; Aphivatanasiri, Chaiwat; Padthaisong, Sureerat; Prajumwongs, Piya; Titapun, Attapol
Savolitinib Plus Osimertinib in Epidermal Growth Factor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase 2 trial

Savolitinib 联合 Osimertinib 治疗表皮生长因子突变、MET 扩增的晚期非小细胞肺癌：一项随机 II 期临床试验

Clinical Lung Cancer
IF3.3
2025-10-220
PRE
James Chih-Hsin Yang; Yuh-Min Chen; Ullas Batra; Kien Hung Do; Piyada Sitthideatphaiboon; Pongwut Danchaivijitr; KangYun Lee; Jarin Chindaprasirt; Cheng-Ta Yang; GeeChen Chang; Chaiyut Charoentum; Teerapat Ungtrakul; Juan Ignacio Hernandez Moran; Ryan Hartmaier; Ike Igwegbe; Alexander Gont; Matthew Haskins; Wanning Xu; Jonathan W. Riess
Prevalence and Related Factors of Post-ERCP Pancreatitis in Cholangiocarcinoma Patients: A Retrospective Study in Northeast Thailand

胆管癌患者ERCP术后胰腺炎的患病率及相关因素：一项在泰国东北部进行的研究

Journal of Clinical Medicine 2025, Vol. 14, Page 7286
IF0
2025-10-150
OAAI
Tanapoom Karntaumporn; Vasin Thanasukarn; Tharatip Srisuk; Vor Luvira; Theerawee Tipwaratorn; Apiwat Jareanrat; Krit Rattanarak; Khanisara Kraphunpongsakul; Natcha Khuntikeo; Jarin Chindaprasirt; Kulyada Eurboonyanun; Prakasit Sa-Ngiamwibool; Watcharin Loilome; Piya Prajumwongs; Attapol Titapun
Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma

鉴定血清代谢物生物标志物和代谢重编程机制以预测胆管癌的复发

SCIENTIFIC REPORTS
IF3.9
2025-04-140
OAAI
Prajumwongs, Piya; Titapun, Attapol; Thanasukarn, Vasin; Jareanrat, Apiwat; Khuntikeo, Natcha; Namwat, Nisana; Klanrit, Poramate; Wangwiwatsin, Arporn; Chindaprasirt, Jarin; Koonmee, Supinda; Sa-Ngiamwibool, Prakasit; Muangritdech, Nattha; Roytrakul, Sittiruk; Loilome, Watcharin
Osimertinib after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable (UR) stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC): Post-progression outcomes from the phase III LAURA study

奥希替尼在局部晚期不可切除（UR）III期表皮生长因子受体突变（EGFRm）非小细胞肺癌（NSCLC）患者（pts）经根治性化疗放疗（CRT）后的应用：来自III期LAURA研究的进展后结局

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Ozguroglu, M.; Ahn, M-J.; Dong, X.; Yang, J. C-H.; Oizumi, S.; Goto, K.; Cobo Dols, M.; Kim, S-W.; Hsia, T-C.; Chindaprasirt, J.; Fujiki, F. K.; Valdiviezo, N.; Poole, L.; Evans, A. L.; Armenteros Monterroso, E.; Lu, S.
Savolitinib (savo) plus osimertinib (osi) vs savo plus placebo (PBO) in patients (pts) with EGFR-mutated (EGFRm), MET-amplified advanced NSCLC with progression on osi
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Yang, James Chih-Hsin; Chen, Yuh-Min; Batra, Ullas; Do, Kien; Sitthideatphaiboon, Piyada; Danchaivijitr, Pongwut; Lee, Kang-Yun; Chindaprasirt, Jarin; Yang, Cheng-Ta; Chang, Gee-Chen; Charoentum, Chaiyut; Ungtrakul, Teerapat; Moran, Juan Ignacio Hernandez; Hartmaier, Ryan; Haskins, Matthew; Xu, Wanning; Riess, Jonathan W.
Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study
JCO GLOBAL ONCOLOGY
IF3
2022-12-0110
OAAI
Charonpongsuntorn, Chanchai; Tanasanvimon, Suebpong; Korphaisarn, Krittiya; Payapwattanawong, Songwit; Siripoon, Teerada; Pakvisal, Nussara; Juengsamarn, Jitlada; Phaibulvatanapong, Ekkamol; Chindaprasirt, Jarin; Prasongsook, Naiyarat; Udomdamrongkul, Kittipong; Ngamphaiboon, Nuttapong; Sirachainan, Ekaphop

研究方向

暂未获取到该数据
P
Panita Limpawattana
H 指数:28论文数:159被引数:6,828
A
Aumkhae Sookprasert
H 指数:15论文数:107被引数:4,860
K
Kosin Wirasorn
H 指数:12论文数:70被引数:415
W
Watcharin Loilome
H 指数:40论文数:235被引数:4,643
A
Attapol Titapun
H 指数:15论文数:73被引数:768
K
Kittisak Sawanyawisuth
H 指数:36论文数:402被引数:4,951
P
Piya Prajumwongs
H 指数:7论文数:31被引数:182
V
Vasin Thanasukarn
H 指数:6论文数:40被引数:109
K
Krittiya Korphaisarn
H 指数:17论文数:92被引数:1,851
P
Piyakarn Watcharenwong
H 指数:4论文数:14被引数:82